Figure 6 | Scientific Reports

Figure 6

From: Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma

Figure 6

Expression of immune checkpoints, m6A genes and sensitivity to chemotherapeutic drugs between the high-risk and low-risk subgroups in TCGA cohort. (A) The expression level of key immune checkpoint genes and (B) m6A genes between the two groups divided by risk score level. (C) The IC50 of six chemotherapeutic drugs compared between high-risk and low-risk groups.

Back to article page